31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Over the past several years, technology has infiltrated more and more aspects of life—including the...
Read More >
“OK Boomer” is having a moment on the internet, appearing often in viral jokes and memes. It is wi...
Read More >
The Department of Homeland Security (DHS) has proposed a new fee schedule designed to mitigate an ap...
Read More >
Distressed companies can be attractive acquisition targets, as their values often reflect the diffic...
Read More >
The New York state legislature has passed a bill that would allow employees making certain claims fo...
Read More >
ConocoPhillips is doubling down on its commitment to the Midland basin by buying Concho Resources In...
Read More >